The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma

Gynecologic Oncology

Volumn 103, Issue 3, 2006, Pages 902-905

  Ayhan, Ali ^a   Bozdag, Gurkan ^a   Taskiran, Cagatay ^a   Gultekin, Murat ^a   Yuce, Kunter ^a   Kucukali, Turkan ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cervical involvement; Endometrial carcinoma; Prognosis; Thrombocytosis

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER GRADING; CANCER PATIENT; CANCER SURGERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SALPINGOOOPHORECTOMY; SURGICAL TECHNIQUE; THROMBOCYTE COUNT; THROMBOCYTOSIS; UTERINE CERVIX CARCINOMA;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PELVIS; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 33751551134     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.05.034     Document Type: Article

References (20)

1. Tranum B.L., and Haut A. Thrombocytosis: platelet kinetics in neoplasia. J Lab Clin Med 84 5 (1974) 615-619
2. Estrov Z., Talpaz M., Mavligit G., Pazdur R., Harris D., Greenberg S.M., et al. Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosis. Am J Med 98 6 (1995) 551-558
3. Bozkurt N., Yuce K., Basaran M., Kose F., and Ayhan A. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer. Obstet Gynecol 103 1 (2004) 82-85
4. Zeimet A.G., Marth C., Muller-Holzner E., Daxenbichler G., and Dapunt O. Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 170 2 (1994) 549-554
5. Hernandez E., Lavine M., Dunton C.J., Gracely E., and Parker J. Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 69 12 (1992) 2975-2977
6. Hernandez E., Donohue K.A., Anderson L.L., Heller P.B., and Stehman F.B. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 78 2 (2000) 137-142
7. Lopes A., Daras V., Cross P.A., Robertson G., Beynon G., and Monaghan J.M. Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer 74 1 (1994) 90-92
8. Menczer J., Geva D., Schejter E., and Zakut H. Elevated platelet count in patients with endometrial carcinoma: correlation with selected prognostic factors and with survival. Int J Gynecol Cancer 6 (1996) 463-466
9. Gucer F., Moser F., Tamussino K., Reich O., Haas J., Arikan G., et al. Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol 70 2 (1998) 210-214
10. Scholz H.S., Petru E., Gucer F., Haas J., Tamussino K., and Winter R. Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res 20 5C (2000) 3983-3985
11. Tamussino K.F., Gucer F., Reich O., Moser F., Petru E., and Scholz H.S. Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer 11 3 (2001) 236-240
12. obstetrics, I.f.o.g.a. Annual report on the results of treatment in gynecologic cancer: corpus cancer staging. Int J Gynecol Cancer 28 (1989) 189-190
13. Menczer J., Schejter E., Geva D., Ginath S., and Zakut H. Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival. Eur J Gynaecol Oncol 19 1 (1998) 82-84
14. Tamussino K.F., Reich O., Gucer F., Moser F., Zivkovic F., Lang P.F., et al. Parametrial spread in patients with endometrial carcinoma undergoing radical hysterectomy. Int J Gynecol Cancer 10 4 (2000) 313-317
15. Boente M.P., Yordan Jr. E.L., McIntosh D.G., Grendys Jr. E.C., Orandi Y.A., Davies S., et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol 51 3 (1993) 316-322
16. Boente M.P., Orandi Y.A., Yordan E.L., Miller A., Graham J.E., Kirshner C., et al. Recurrence patterns and complications in endometrial adenocarcinoma with cervical involvement. Ann Surg Oncol 2 2 (1995) 138-144
17. Ayhan A., Al R.A., Baykal C., Demirtas E., and Yuce K. A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma. Int J Gynecol Cancer 14 2 (2004) 279-285
18. Ayhan A., Al R.A., Baykal C., Demirtas E., and Yuce K. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. Int J Gynecol Cancer 14 2 (2004) 286-292
19. Selman T.J., Luesley D.M., Murphy D.J., and Mann C.H. Is radical hysterectomy for early stage cervical cancer an outdated operation?. BJOG 112 3 (2005) 363-365
20. Manfredi R., Mirk P., Maresca G., Margariti P.A., Testa A., Zannoni G.F., et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231 2 (2004) 372-378